CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,682,000 | -93.1% | 21,026 | -91.4% | 0.04% | -92.9% |
| Q2 2018 | $24,202,000 | -53.1% | 243,652 | -61.8% | 0.54% | -52.5% |
| Q1 2018 | $51,658,000 | +3.2% | 637,752 | +0.3% | 1.13% | +3.8% |
| Q4 2017 | $50,078,000 | +52.3% | 635,752 | +78.5% | 1.09% | +42.4% |
| Q3 2017 | $32,872,000 | – | 356,252 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 149,457 | $11,773,000 | 6.29% |
| INDUS CAPITAL PARTNERS, LLC | 330,339 | $26,021,000 | 2.54% |
| Perpetual Ltd | 129,799 | $10,215,000 | 1.32% |
| Black Creek Investment Management Inc. | 396,525 | $31,234,000 | 1.18% |
| RUDMAN ERROL M | 28,701 | $2,261,000 | 1.10% |
| COMGEST GLOBAL INVESTORS S.A.S. | 635,752 | $50,078,000 | 1.09% |
| Antipodean Advisors LLC | 15,000 | $1,182,000 | 0.96% |
| Hillhouse Capital Management | 618,391 | $48,711,000 | 0.83% |
| JUPITER ASSET MANAGEMENT LTD | 215,866 | $17,004,000 | 0.49% |
| Temasek Holdings (Private) Ltd | 990,000 | $77,982,000 | 0.48% |